
2. Oncogenesis
- Cancer biology and genetics
- Hereditary cancer
- Genetic cancer risk assessment and when to refer
- Precision medicine
Elisabeth King (Moderator)
DNP, MBA, FNP, AOCNP, AGN, CENP
Tampa General Hospital (TGH) Cancer Institute
Dr. Elisabeth King is the Chief Operating Officer of the Tampa General Hospital (TGH) Cancer Institute, where she leads strategic and operational initiatives to deliver cutting-edge oncology care across the region. In this role, she advances clinical excellence, multidisciplinary collaboration, and access to equitable cancer care, with a strong focus on scaling innovation and improving the patient and provider experience.
Prior to joining TGH Cancer Institute, Elisabeth served as the Executive Director of Nursing at City of Hope, where she led system-wide initiatives in genomics, nursing leadership, and care transformation across both inpatient and ambulatory cancer services.
Elisabeth earned her BS in Biology from the University of Texas at Austin, an ADN from Austin Community College, and an MSN from Frontier Nursing University. She completed both her Doctor of Nursing Practice (DNP) and MBA at Johns Hopkins University.
She is board-certified as a Family Nurse Practitioner, Advanced Oncology Certified Nurse Practitioner (AOCNP), Advanced Genetics Nurse (AGN-BC), and in Executive Nursing Practice (CENP). A recognized leader in cancer care and health system innovation, Elisabeth frequently speaks on cancer genetics, nursing leadership, and driving transformation in complex healthcare environments.
Elisabeth King has no relevant financial relationships to disclose.
- Explain the biological mechanisms that drive hereditary and somatic cancer.
- Identify indications for referral to hereditary cancer genetics.
- Interpret tumor genomic profiling results to guide targeted therapy decisions.
Key:




